Compare MDT & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDT | CI |
|---|---|---|
| Founded | 1949 | 1792 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.3B | 79.0B |
| IPO Year | 2014 | 2018 |
| Metric | MDT | CI |
|---|---|---|
| Price | $80.48 | $282.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 15 |
| Target Price | $108.21 | ★ $349.00 |
| AVG Volume (30 Days) | ★ 11.0M | 1.4M |
| Earning Date | 06-03-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.58% | 2.13% |
| EPS Growth | 3.32 | ★ 83.00 |
| EPS | 3.73 | ★ 6.26 |
| Revenue | $36,364,000,000.00 | ★ $274,900,000,000.00 |
| Revenue This Year | $8.91 | $5.91 |
| Revenue Next Year | $6.54 | $5.92 |
| P/E Ratio | ★ $21.56 | $45.03 |
| Revenue Growth | 8.43 | ★ 11.24 |
| 52 Week Low | $73.31 | $239.51 |
| 52 Week High | $106.33 | $338.89 |
| Indicator | MDT | CI |
|---|---|---|
| Relative Strength Index (RSI) | 53.51 | 46.34 |
| Support Level | $77.62 | $280.76 |
| Resistance Level | $82.83 | $294.33 |
| Average True Range (ATR) | 1.70 | 6.25 |
| MACD | 0.16 | -1.16 |
| Stochastic Oscillator | 59.88 | 25.98 |
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.